Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg
TED · 304490-2026can-standardawardedNo deadline given
Buyer
NameServicio Murciano de Salud - Junta de Compras
CountryES
Published2026-05-05
Deadline—
Value
Estimated—
Awarded€2,901,898 · 2,901,898.04 EUR
WinnerFRESENIUS KABI ESPAÑA, S.A. | BIOCON BIOLOGICS SPAIN, S.L. | JANSSEN CILAG, S.A. | SANDOZ FARMACEUTICA S.A.
CPV codes
33652300 Medical equipment & pharmaceuticalsDescription
Suministro de medicamentos con principios activos Ustekinumab y Adalimumab 80 mg para los Centros dependientes del Servicio Murciano de Salud
Similar tenders
Closest by meaning — across languages, via embeddings.
Records136,978 tendersNewest notice2026-06-24Last ingest2026-06-25 · TED daily 06:00Parser health (7d)all runs clean